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Involvement of CTCF in 
transcription regulation of EGR1 at 
early G1 phase as an architecture 
factor
Takeshi Sekiya1, Kohsuke Kato1,2, Atsushi Kawaguchi1,2 & Kyosuke Nagata2
Early growth response 1 (EGR1) is a transcription factor and regulates cellular processes such as 
proliferation, differentiation, and apoptosis. The expression of EGR1 is rapidly induced in response 
to several stimuli, and it activates the expression of downstream target genes involved in signaling 
cascades. EGR1 gene is also known to be transcribed in early G1 phase. However, the regulation of EGR1 
transcription in early G1 phase is not clarified well. Here we found that CCCTC-binding factor (CTCF), a 
chromatin binding protein, is required to transcribe EGR1 gene at the onset of early G1 phase. We found 
that CTCF mediated the formation of higher-order chromatin structures among CTCF binding sites 
located in the EGR1 locus. Disruption of the CTCF-dependent higher-order chromatin structure using 
nuclease-dead Cas9 (dCas9)-mediated interference reduced the EGR1 transcription in early G1 phase. 
Collectively, we propose that CTCF has functional roles for the temporal expression of EGR1 in early G1 
phase through regulation of higher-order chromatin structure organization.
Immediate early genes (IEGs) are a set of cellular genes, and transcription of mRNAs from which is rapidly 
induced by both extracellular and intracellular signals through several factors which does not requires de novo 
protein synthesis1. Most IEGs encode transcription factors involved in initiation of signaling cascades by mod-
ulating transcription of the target genes. EGR1 belongs to IEGs and is transcribed rapidly and transiently in 
response to various kinds of stimuli2. EGR1 functions as both an activator and a repressor for transcriptional 
regulation of numerous genes, including EGF, TGF-β, and Bax, in concert with several cofactors3,4 to control cell 
growth, tumorigenesis5, and apoptosis6. Analyses of the EGR1 promoter revealed that a number of cis-elements 
are located within 720 bp upstream of the EGR1 transcription start site (TSS)7. It has been proposed that several 
serum response elements (SREs) located at approximately 300 bp upstream of the EGR1 TSS have a crucial role 
for the expression of EGR17. Serum response factor (SRF) binds to SREs by interacting with TCF co-regulator 
proteins in a phosphorylation-dependent manner8. It has been reported that the expression of EGR1 was induced 
in early G1 phase9. Because SRF-TCF complex is activated in early G1 phase by growth factors to induce genes 
involved in G1 progression10, EGR1 is thought to be regulated by SRF-TCF complex in early G1 phase. From 
functional analyses of CTCF in the EGR1 expression, CTCF was thought to function as a negative regulator 
during mouse myeloid cell differentiation or in LPS-stimulated macrophages11. CTCF binding motif is located 
at approximately 1.2 kb upstream of the EGR1 TSS11. CTCF is a DNA binding protein possessing C2H2 zinc 
finger motifs and was originally found as a repressor of c-myc12 and lysozyme13. CTCF is a highly conserved mul-
tifunctional protein in vertebrates. CTCF functions not only as a transcription factor with a variety of binding 
partners14, but also a regulator of higher-order chromatin structure through the formation of chromatin loops 
that define the boundary between transcriptionally active and inactive chromatin15. Recently we reported that 
CTCF is highly phospholylated in mitosis and the phosphorylation of CTCF impairs its DNA binding activity16. 
In parallel with the reformation of nucleus at telophase, dephosphorylation of CTCF and its recruitment on 
chromatin might occur, although a phosphatase(s) involved in this process is Unknown. Higher order chroma-
tin structures, including structures possibly regulated by CTCF, are disrupted in mitosis and reformed in G1 
phase17. Regulation of gene expressions through higher-order chromatin structures are observed through whole 
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Figure 1. CTCF was associated with EGR1 promoter and stimulated its transcription in early G1 phase. (A) 
Expression level of CTCF in CTCF KD cells. HeLa S3 cells were transfected with shEGFP expression plasmid 
as a control (shEGFP, lanes 1–3) or shCTCF#1 expression plasmid (shCTCF#1, lanes 4–6), or shCTCF#2 
expression plasmid (shCTCF#2, lanes 7–9). Lysates from desired cell numbers (0.25 × 105, 0.5 × 105, and 
1 × 105) were subjected to western blot analyses using anti-CTCF and anti-α-tublin antibodies. The original 
blots are presented in Supplementary Fig. S9. (B) Effect of CTCF KD on transcription in early G1 phase. 
HeLa S3 cells transfected with shEGFP (blue line and diamonds) or shCTCF#1 (red line and squares), or 
shCTCF#2 (green line and triangles) expression plasmid were synchronozied and arrested with nocodazole. 
Total RNAs were extracted from cells collected at indicated time points after nocodazole release and subjected 
to qRT-PCR using specific primers for EGR1 pre-mRNA, CCND1 pre-mRNA, and 28 S rRNA. The amounts 
of pre-mRNA levels were normalized by the amount of 28 S rRNA, and then relative expression levels were 
shown. (C) Expression level of EGR1 in CTCF KD cells in early G1 phase. HeLa S3 cells were transfected with 
shEGFP expression plasmid (shEGFP, lanes 1–4) or shCTCF#1 expression plasmid (shCTCF#1, lanes 5–8). 
Lysates from cells collected at indicated time points were subjected to western blot analyses using anti-EGR1 
and anti-α-tublin antibodies. The original blots are presented in Supplementary Fig. S9. (D) ChIP analysis 
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cell cycles. In particular, early G1 phase may be a time in which profound reformation of higher-order chromatin 
structure and transcription restart simultaneously proceed. Thus, CTCF might be involved in the expression of 
early G1 genes, such as EGR1. However, the precise function of CTCF in the EGR1 expression in early G1 phase 
is not well known.
Here, we have shown that CTCF is required for the transcription of EGR1 in early G1 phase. Chromatin 
Immunoprecipitation (ChIP) and Chromosome Conformation Capture (3 C) analyses indicated that 
CTCF-mediated higher-order chromatin structure is formed among the promoter and the upstream and the 
downstream CTCF-binding sites of the EGR1 gene locus after mitotic exit. dCas9-mediated interference of the 
formation of higher-order chromatin structure in early G1 phase also reduced EGR1 transcription. Collectively, 
these results suggest that CTCF is important for the temporal transcription regulation of EGR1 through its func-
tion in the organization of higher-order chromatin structure.
Results
CTCF is required for the expression of the EGR1 gene in early G1 phase. To know whether CTCF 
is involved in the expression of EGR1 in early G1 phase, we examined the effect of CTCF knockdown (KD) on 
the EGR1 transcription level in early G1 phase. In CTCF KD cells, using plasmids expressing shRNA against 
CTCF (shCTCF#1 and #2), the expression level of the CTCF proteins was less than 25% of that in the control cells 
(Fig. 1A). At 63 h post transfection of the shRNA expression plasmid, HeLa S3 cells were treated with 165 nM of 
nocodazole for 6 h, as described in the Experimental procedures. The expression levels of CTCF were not affected 
by cell cycle synchronization (Supplementary Fig. S1). After removal of the drug, the cells were incubated at 37 °C 
to synchronize the cell population in early G1 phase. Total RNAs were isolated from the cells and subjected to 
qRT-PCR using the primers that span the exon-intron junctions. Along with the progression of G1 phase, the 
expression level of EGR1 pre-mRNA was peaked at 2 h post release and quickly reduced at 3 h post release in the 
control cells (Fig. 1B). In contrast, the EGR1 transcription level in CTCF KD cells had decreased to less than 30% 
of that in the control cells at 2 h post release (Fig. 1B). These results indicate that CTCF is a positive regulator 
of EGR1 transcription in early G1 phase. We also examined the pre-mRNA level of CCND1 gene which is also 
expressed in G1 phase and has putative CTCF binding sites18. The amount of CCND1 pre-mRNA was reduced 
in CTCF KD cells compared with that of control cells, suggesting that CTCF also regulates CCND1 transcription 
in G1 phase. Similar results were obtained from shCTCF#1 and shCTCF#2. The cell cycle progression profiles of 
the control and CTCF KD cells were not significantly changed (Supplementary Fig. S2). Notably, the expression 
of EGR1 protein also reduced in CTCF KD cells in early G1 phase (Fig. 1C). To clarify the role(s) of CTCF in 
the transcriptional regulation of EGR1, we examined the binding of CTCF to a CTCF binding site located 1.2 kb 
upstream11 of the EGR1 TSS during early G1 phase. ChIP assays were performed using lysates prepared from 
HeLa S3 cells at 0, 1, 2 and 3 h post release from nocodazole treatment. As expected, CTCF interacted with the 
CTCF binding site in the EGR1 promoter after nocodazole release and its binding was observed during cell cycle 
progression (Fig. 1D).
CTCF does not affect early G1 transcription from the EGR1 promoter in a reporter plasmid 
system. It has been reported that CTCF plays a role in transcriptional regulation through interactions 
with transcription-related factors independently of higher-order chromatin structure formation19,20. To reveal 
the function(s) of CTCF in the EGR1 transcription in early G1 phase, we used a luciferase reporter system to 
analyze the effect of CTCF bound to the promoter on EGR1 transcription in early G1 phase. A DNA fragment 
corresponding to the promoter region between −720 bp and + 120 bp of the EGR1 TSS was amplified by PCR 
and cloned into a luciferase reporter plasmid (pEGR1 pro-720/+120 Luc). We also constructed a luciferase 
reporter plasmid containing a DNA fragment between −1358 bp and + 120 bp of the EGR1 TSS (pEGR1 pro-
1358/+120 Luc) containing a promoter-proximal CTCF binding site located at the nucleotide position between 
−1227 bp and −1208 bp of the EGR1 TSS. pEGR1 pro-1358/+120ΔCTCF BS Luc has mutated nucleotide 
sequences of the promoter-proximal CTCF binding site (Figs 2A and S3A). The amounts of CTCF on pEGR1 pro-
1358/+120ΔCTCF BS Luc decreased to 25% of that on pEGR1 pro-1358/+120 Luc (Supplementary Fig. S3B). 
However, no significant differences in the luciferase activity were found among cells transfected with plasmids 
pEGR1 pro-720/+120 Luc, pEGR1 pro-1358/+120 Luc, or pEGR1 pro-1358/+120ΔCTCF BS Luc (Fig. 2B). 
These results indicate that, in the reporter plasmid-based assay system, the promoter-proximal CTCF binding 
site does not have any functions to the EGR1 expression. This indicates that CTCF-mediated EGR1 activation 
requires other CTCF binding sites in the EGR1 locus in addition to the promoter-proximal binding site. Based on 
ChIP-sequence data from ENCODE project18, it is assumed that CTCF may bind to upstream and downstream 
of the EGR1 gene locus (Supplementary Fig. S4). To confirm that CTCF binds to these loci, ChIP assays were 
performed using lysates prepared as described in Fig. 1. Figure 3B shows that CTCF binds to upstream (15 kb 
from the EGR1 TSS) and downstream (38 kb from the TSS) sites in the EGR1 gene locus in early G1 phase. Both 
the upstream and downstream CTCF binding sites showed similar increment patterns of CTCF binding as seen 
for quantification of the level of CTCF associated with the promoter-proximal CTCF binding site in early G1 
pahse. Eary G1 cells were collected at indicated time points after release, and ChIP assays were performed 
using with anti-CTCF antibody and rabbit normal IgG. qPCR was performed with primers for amplification 
of DNA including CTCF binding sites located the 1.2 kb upstream of the EGR1 gene transcription start site 
(TSS). The relative amount of DNA co-immunoprecipitated with each antibody was shown as % of input. Data 
information: Each error bar shows standard deviation of three independent experiments. Student’s two tailed 
t-test, *P < 0.05, ns, P > 0.05.
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in the promoter-proximal CTCF binding site in early G1 phase (Fig. 1D). These results led us to examine the 
long-range chromatin interaction among the upstream, promoter, and downstream CTCF binding sites in the 
EGR1 gene locus (Fig. 4).
CTCF is involved in the formation of higher-order chromatin organization in the EGR1 locus. 
To address whether long-range chromatin interactions exist in the EGR1 locus, we performed 3 C analyses using 
primer sets indicated in Table 1 to identify a physical interaction between two separate genomic regions21. After 
crosslinking, the genomic DNA was digested with a restriction enzyme and subjected to ligation followed by 
PCR using primers corresponding to regions between 15 kb upstream and the promoter, 38 kb downstream and 
the promoter, and 15 kb upstream and 38 kb downstream (Fig. 4A). In control cells, amplified PCR products 
derived from any combinations among the EGR1 upstream, promoter, and downstream regions were observed 
in a time-dependent manner after nocodazole release, indicating the close proximity of each these two sepa-
rate regions forms in early G1 phase (Fig. 4B, lanes 1–4, 9–12, and 17–20). We did not observe any amplified 
PCR products using primers corresponding to the Igf2 downstream and EGR1 promoter regions (Supplementary 
Fig. S5), suggesting that the observed PCR signals in the EGR1 locus reflect specific interactions between the two 
separate genomic regions. Igf2 is a gene known to be regulated by CTCF and located on chromosome 11 which 
is different that of EGR1. Thus, Igf2 and EGR1 might be not close each other in the nucleus. The PCR products 
were reduced or not observed in CTCF KD cells (Fig. 4B, lanes 5–8, 13–16, 21–24), indicating that the long-range 
chromatin interactions observed in the EGR1 locus were dependent on CTCF. From these results, it is possible 
that CTCF regulates EGR1 transcription in early G1 phase as a chromatin organizer.
However, the results observed in the CTCF KD condition were potentially caused by an indirect effect due to 
the abundant existence of CTCF binding sites in whole genomic DNA. To investigate whether CTCF-mediated 
long-range chromatin interactions in the EGR1 locus are required for transcription in early G1 phase, we devel-
oped a dCas9-mediated interference method to inhibit CTCF function in the EGR1 locus. CRISPR-associated 
endonuclease Cas9 is recruited through RNA-DNA base pairing between Cas9-guide RNA (gRNA) and a spe-
cific target DNA sequence, resulting in the induction of a double-strand DNA break22. Because dCas9 has two 
alanine substitutions at amino acid positions 10 and 840 (aspartic acid and histidine, respectively), dCas9 has 
gRNA-dependent DNA binding activity but not nuclease activity. Thus, the dCas9-gRNA complex is recruited 
to a specific chromatin site without DNA damages23. To bring about interference of CTCF at each CTCF bind-
ing site, we designed gRNA sequences covering each of the CTCF binding sites. Cells were transfected with a 
plasmid construct expressing both 3× FLAG tagged dCas9 and gRNA. The gRNA targets were either a control 
nonspecific sequence (non-homologous with any CTCF binding sites in the EGR1 locus), the upstream, down-
stream, or promoter proximal CTCF binding site in the EGR1 locus (Supplementary Fig. S6). The cells were 
synchronized in prometaphase with nocodazole. At 0, 1, 2 and 3 h post release from nocodazole arrest, total 
RNAs were isolated and subjected to qRT-PCR for quantification of EGR1 pre-mRNA. Compared with the cells 
expressing dCas9 with nonspecific gRNA, the cells expressing dCas9 with specific gRNA against the upstream, 
Figure 2. CTCF did not affect early G1 transcription from the EGR1 promoter in reporter plasmid-transfected 
cells. (A) Schematic diagram of human EGR1 promoter luciferase reporter plasmids. (B) The CTCF binding 
site (BS) located at 1.2 kb upstream of TSS is not required for temporal transcription regulation of EGR1 in early 
G1 phase. HeLa S3 cells were transfected with pEGR1 pro-720/+120 Luc, pEGR1 pro-1358/+120 Luc, pEGR1 
pro-1358/+120ΔCTCF BS Luc plasmids together with pRL-SV40 as a normalizer. Cells were synchronized and 
arrested by nocodazole. Eary G1 cells were collected at indicated time points after release. The firefly luciferase 
activity was normalized with the renilla luciferase activity and represented as relative values. Data information: 
Each error bar shows standard deviation of three independent experiments. Student’s two tailed t-test, ns, P > 0.05.
www.nature.com/scientificreports/
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downstream, or promoter CTCF binding site showed reduced EGR1 transcription in early G1 phase at 2 h post 
release (Fig. 5A). It is noteworthy that the effect of gRNA expression was specifically observed in transcription of 
EGR1 but not CCND1, suggesting that the effect of gRNAs is highly specific for EGR1 gene. The ChIP assays of 
dCas9 demonstrated that the gRNAs specifically interacted with each target site in the EGR1 locus (Fig. 5B). To 
analyze whether dCas9 competes with CTCF for these binding sites, sequential ChIP analyses (termed re-ChIP) 
were performed. dCas9-bound chromatin was concentrated by immunoprecipitation with anti-FLAG antibody 
and then were subjected to further immunoprecipitation with control IgG, ani-CTCF, and anti-FLAG antibodies, 
respectively (Supplementary Fig. S7). We found that CTCF was not observed on the upstream (Supplementary 
Fig. S7, upper graph, lanes 5), the downstream (Supplementary Fig. S7, middle graph, lanes 8), and the promoter 
proximal CTCF binding sites (Supplementary Fig. S7, lower graph, lanes 11) by expressing gRNAs targeting to 
these sites, respectively. We also examined the EGR1 transcription in cells transfected with two or three gRNAs 
targeting to the CTCF binding sites (Fig. 5C). The level of EGR1 pre-mRNA but not CCND1 pre-mRNA was 
reduced more than that with single gRNA transfected cells (Figs 5C and S8). To examine whether dCas9 expres-
sion also disrupts higher-order chromatin interactions at the EGR1 locus, 3 C analyses were performed with cells 
expressing dCas9 and gRNAs against the CTCF binding sites in the EGR1 locus (Fig. 6). We observed that the 
interactions of the upstream-downstream regions (Fig. 6C,D) and the promoter-downstream regions (Fig. 6E,F), 
but not the upstream-promoter regions (Fig. 6A,B), decreased by expressing dCas9-gRNA against CTCF bind-
ing sites in EGR1 locus. Further, we also found that all three CTCF binding sites are required for the long-range 
interactions of the upstream-downstream and promoter-downstream regions. The CTCF binding sites located 
on upstream and promoter in the EGR1 locus are on the forward strand (the coding strand of EGR1), while 
the downstream CTCF binding site of the EGR1 locus is on the reverse strand (the template strand of EGR1). 
Because, it is reported that two CTCF binding sites located in convergent orientation interacts more often than 
that of located in the same orientation24. The 3 C interaction of the upstream-promoter region seems weaker com-
pared with others (Fig. 6B). This might be due to the orientation of CTCF motif on each CTCF binding site in the 
EGR1 locus. Notably, the interaction between the upstream and downstream regions of Igf2 was not affected by 
dCas9-gRNAs for the EGR1 locus (Fig. 6B, bottom graph). These results suggest that the dCas9-gRNA complexes 
interfere with the binding of CTCF to the EGR1 upstream, downstream, or promoter CTCF binding site, and 
consequently the formation of 3 C interaction was disturbed. Therefore, it is concluded that CTCF mediates the 
long-range chromatin interactions among the CTCF binding sites in the EGR1 locus. The interactions between 
upstream-downstream and promoter-downstream might be important for the expression of EGR1 in early G1 
phase.
Figure 3. CTCF bound upstream and downstream CTCF binding sites in early G1 phase. (A) Schematic 
diagram of the human EGR1 gene locus and CTCF binding sites. (B) ChIP analysis for quantification of the 
CTCF level associated with the distal CTCF binding sites. The lysates were prepared as described in the legend 
for Fig. 1D and subjected to immunoprecipitation with anti-CTCF antibody and rabbit normal IgG. qPCR 
was performed with primer sets for amplification of the upstream or downstream CTCF bindig sites of the 
EGR1 gene. The amount of DNA co-immunoprecipitated with each antibody was shown as % of input. Data 
information: Each error bar shows standard deviation of three independent experiments. Student’s two tailed 
t-test, ns, P > 0.05.
www.nature.com/scientificreports/
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Discussion
EGR1 regulates several cellular processes such as cell proliferation and apoptosis as a transcription factor2. It 
has been reported that EGR1 is transcribed in early G1 phase9. In general, transcription factors are the primary 
determinants of the transcription regulation. However, the molecular mechanism of the cell cycle-specific 
transcription of EGR1 is not well understood. It has been reported that CTCF binds to the promoter-proximal 
CTCF binding site of EGR1 and negatively regulates its transcription during myeloid cell differentiation or 
LPS-stimulated macrophages11. Here, we examined whether CTCF is involved in cell cycle-dependent transcrip-
tion of the EGR1. We found that the expression of EGR1 pre-mRNA in early G1 phase is reduced by knockdown 
of CTCF, suggesting an involvement of CTCF in the cell-cycle specific transcription of EGR1 as a positive regu-
lator (Fig. 1B). CTCF is known as a multi-functional protein15 and activates mRNA synthesis through its inter-
action with transcription-related factors such as the largest subunit of RNA polymerase II, RBP1/POLR2A19, or 
the general transcription factor TFII-I20. However, the promoter-proximal CTCF binding site did not activate the 
transcription from transiently transfected reporter plasmid in early G1 phase (Fig. 2). The inhibition of CTCF 
by shRNA or dCas9-gRNA resulted in reduced expression of EGR1 pre-mRNA in early G1 phase (Figs 1 and 5) 
and impairment of chromatin-loop structures (Figs 4 and 6). The expression level of EGR1 pre-mRNA showed 
sharp increment and decrement during early G1 phase (Figs 1B and 5A,C). During the period from 0 to 2 h post 
release from nocodazole block, CTCF-mediated higher-order chromatin structures within the EGR1 gene locus 
might be required for its maximum transcription in early G1 phase. After that, the expression levels of EGR1 
pre-mRNA were decreased at 3 h post nocodazole release. However, binding levels of CTCF on each CTCF bind-
ing site (Figs 1C and 3B) and the formation of higher order chromatin structures in the EGR1 locus (Fig. 4B) 
did not show the similar fluctuating patterns to that of the EGR1 pre-mRNA levels. It might suggest that there 
is the inhibitory mechanism(s) of the EGR1 expression which is controlled independently of CTCF-mediated 
Figure 4. CTCF is involved in the organization of higher-order chromatin structure in the EGR1 locus in early 
G1 phase. (A) Schematic diagram of the human EGR1 gene locus and the PCR primers used for 3 C assays. 
Black and white arrows indicate primers for the first PCR and the second (nested) PCR, respectively to analyze 
interactions between upstream-promoter, upstream-downstream or promoter-downstream of the EGR1 gene 
locus. The number of each primer is corresponding to that of in Table 1. The white inverted triangle indicates 
position of recognition sequence of restriction enzyme Dpn II. (B) HeLa S3 cells were transfected with shEGFP 
or shCTCF#1 expression vector. Cells were synchronized and arrested by nocodazole. Eary G1 cells were 
collected at indicated time points after nocodazole release, and then subjected to 3 C assay. The first round 
PCR was performed for 20 cycles, subsequently the second round PCR was performed by 30 cycles with nested 
primers. Results of two independent experiments (Exp. #1 and Exp. #2) are shown. The original gel images are 
presented in Supplementary Fig. S10.
www.nature.com/scientificreports/
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higher-order chromatin structures. The gRNA against the promoter proximal CTCF binding site reduced the 
expression of EGR1 in early G1 phase, suggesting that there is a functional significance of the promoter proximal 
CTCF binding site on the EGR1 expression, even though it can not be reconstituted in transiently transfected 
plasmid lacking additional CTCF binding sites. These results suggest that higher order interactions between the 
promoter proximal CTCF binding site and other CTCF binding sites are important for its proper function. It 
has been reported that nucleosomes surrounding a CTCF binding site are well positioned25. Hence, we can not 
exclude the possibility that the local chromatin structure around the promoter proximal CTCF binding site might 
be important for its function in the EGR1 locus because nucleosome positioning on transiently transfected DNA 
is usually different from that of native chromatin26. It has been reported that in mouse erythroblast cells, chro-
matin loop structure is generally disrupted in mitosis and increased sharply until early G1 phase (60–90 min 
post nocodazole release)27. Reformation of chromatin loop structures occur independently of its gene expression 
patterns during cell cycle, although the functional relationship between chromatin loop structures and its direct 
contribution to a gene expression is not clear27. Our findings suggest that the formation of higher order chromatin 
structures in the EGR1 locus in early G1 phase may contribute to the expression of the EGR1 pre-mRNA in early 
G1 phase. Enhancers regulate transcription of their target genes through the binding of transcription factors in a 
distance-independent manner28. It has been suggested that distal enhancers and their target promoters are closely 
positioned in three dimensional space through higher order chromatin structures to establish a microenviron-
ment to regulate efficient gene expressions29. The enhancer database predicts a possibility of the presence of cell 
type specific putative enhancer elements in the human EGR1 gene locus30. These putative enhancer elements may 
contribute to an optimal induction of EGR1 in early G1 phase mediated by CTCF.
Not only EGR1 but also other early G1 genes9 have CTCF binding sites in their gene loci (Supplementary 
Table S1), which suggests possible contribution of CTCF to expression of those genes via higher-order chromatin 
structure formation. However, it remains unclear whether our findings of CTCF involvement in the expression 
of the EGR1 gene in the early G1 phase through higher-order chromatin structure formation could be expanded 
to other early G1 expression genes. Because of the technological limitation of PCR-based one-by-one analysis of 
higher-order chromatin interaction in being unable to handle multiple loci, several modified 3C-based methods 
have been developed to overcome this problem. Among these methods, the Hi-C technique31 is a practical meth-
ods to analyze genomewide chromatin interactions, especially in megabase-scale chromatin domain structures. 
Recently, it was reported that a modified Hi-C technique, called the in situ Hi-C protocol24, can be used to make 
a kilobase-scale high resolution interaction map. Analyses using such techniques may allow us to obtain more 
insights into the functional contribution of CTCF to the early G1 phase gene expression through higher-order 
chromatin structure formation.
Methods
Cell culture, transfection and synchronization. HeLa S3 cells were maintained at 37 °C in DMEM sup-
plemented with 10% FBS. Cells were transfected with pU6-puro-shCTCF or pU6-puro-shEGFP32 plasmid using 
NEON transfection system (Thermo Fisher Scientific). After 20 h post transfection, puromycin was added in the 
medium at the concentration of 2 μg/ml, and cells were incubated further for 20 h. After selection in the presence 
of puromycin, mitotic cells synchronized with nocodazole were collected. Briefly, cells were treated with 2.5 mM 
thymidine (Sigma) in the culture medium for 16 h. Thymidine blocked cells were released into a fresh culture 
medium and incubated for 7 h, so that cells stayed in late S and G2 phases. Then, cells were treated with noco-
dazole (Sigma) at a final concentration of 165 nM and further incubated for 6 h. Mitotic cells were collected by 
gentle shaking of cell culture dishes. For release of cells from mitosis, nocodazole-arrested cells were reattached to 
poly-L-lysine coated culture dishes, then washed with PBS, and cultured for indicated periods.
Preparation of plasmids. To generate pU6-puro-shCTCF#1 plasmid, which expresses 21 nucleotides-long 
hairpin-type shRNA against human CTCF, corresponding to the sequence between nucleotide positions 868 and 
888 (NCBI Reference Sequence: NM_006565.3), 5′-CACCGTGTCTAAAGAGGGTCTTGTGGTGTGCTGTCCCG 
CAAGGCCCTCTTTAGACACTTTTTT-3′ and 5′-GCATAAAAAAGTGTCTAAAGAGGGCCTTGCGGGACA 
GCACACCACAAGACCCTCTTTAGACAC-3′ oligonucleotides were phosphorylated, annealed each other, 
and cloned into pU6-puro32 that had been digested with BspM I. Oligonucleotides corresponding to the sequence 
between nucleotide positions 2,819 and 2,839 (NM_006565.3), 5′-CACCGTAAATTATGGAGTGTTCTGATTG 
ATATCCGTCAGAACATTCCATGATTTGCTTTTTT-3′ and 5′-GCATAAAAAAGCAAATCATGGAATGTTCT 
GACGGATATCAATCAGAACACTCCATAATTTAC-3′ were used to generate pU6-puro-shCTCF#2 plasmid. 
The human EGR1 promoter was amplified by PCR using the genomic DNA extracted from HeLa S3 cells as template 
For first PCR For second PCR
For 3C-PCR
EGR1 upstream 1 GCACCGTTTCAGGCAGGACACACACAAAAG 2 CTGACCCAGCTCAGAGAGGGAGAAAC
EGR1 promoter 3 CTGCTATACAGTGTCCCAAGAACCAAGTG 4 TCCCAGCGACACCCGGAAAGACACCGTGCC
EGR1 downstream 5 CACTTCCAGAGGACCAAGGTTGGGAGAGGA 6 TCCCAGTCCTTGCTAAGTGCCTTCATGTGC
Igf2 upstream 7 CTCACCTGTCTCCATAAAGCATGTGTCC 8 CCTTGCGTGGAAAATCTGTGGAATGTAG
Igf2 downstream 9 CTGCAAGGTCAGGGGACATTGTTCAGGG 10 GACATTGTTCAGGGTGGGAGGTGAGTGG
rRNA forward 11 GCCCTTGCGGTGCTCCTGG
rRNA reverse 12 ACACACCACCGTTCGGCCTC
Table 1. Primer list for Figs 4 and 6.
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Figure 5. dCas9-mediated interference analysis. (A) dCas9-mediated specific interference of EGR1 expression 
in early G1 phase. HeLa S3 cells were transfected with the plasmid expressing dCas9 with control gRNA 
(Control), gRNA against the 15 kb upstream (Upstream), gRNA against the 38 kb downstream (Downstream), 
and gRNA against the 1.2 kb upstream (Promoter). Cells were synchronized and arrested by nocodazole. Eary 
G1 cells were collected at indicated time points after nocodazole release. Total RNAs were extracted from 
collected cells and subjected to qRT-PCR using specific primer sets for EGR1 pre-mRNA, CCND1 pre-mRNA, 
and 28 S rRNA. The amounts of pre-mRNA were normalized by the amount of 28 S rRNA, and the relative 
expression levels were shown. Each error bar shows standard deviation of three independent experiments. 
Asterisks indicate a significant difference level (Student’s two tailed t-test, *P < 0.05). (B) ChIP analyses for 
a quantification of DNA associated with 3× FLAG tagged dCas9 and gRNA complexes. HeLa S3 cells were 
transfected with dCas9 and gRNA expression vectors and prepared early G1 cells as shown in (A), and ChIP 
assays were performed using anti-FLAG antibody. qPCR was performed with primer sets for amplification of 
15 kb upstream (Upstream) and 38 kb downstream (Dpwnstream), and 1.2 kb upstream (Promoter) of the EGR1 
TSS. The relative amount of DNA co-immunoprecipitated with anti-FLAG antibody was shown as % of input. 
Error bar represents standard deviation (n = 2). (C) Simultaneous transfection of two or three kinds of gRNAs. 
HeLa S3 cells were transfected with the plasmid expressing dCas9 with control gRNA (Control), gRNAs against 
15 kb upstream and 38 kb downstream (Up + Down), gRNAs against 15 kb upstream and 1.2 kb upstream 
(Up + Pro), gRNAs against 1.2 kb upstream and 38 kb downstream (Pro + Down), gRNAs against 15 kb 
upstream and 38 kb downstream and 1.2 kb upstream (Up + Down + Pro). Cells were collected and qRT-PCR 
analyses were performed as described in Fig. 5A. Each error bar shows standard deviation of three independent 
experiments. Asterisks indicate a significant difference level (Student’s two tailed t-test, *P < 0.05).
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Figure 6. Effect of the dCas9-gRNA expression on chromatin interactions in the EGR1 gene locus in early G1 
phase. HeLa S3 cells were transfected with the plasmid expressing dCas9 with gRNA. Cells were synchronized 
and arrested by nocodazole. Eary G1 cells were collected at indicated time points after nocodazole release, 
and subjected to 3 C assay. The first round PCR was performed for 20 cycles, subsequently the second round 
PCR was performed by 30 cycles with nested primers. (A,C,E,G) PCR products were separated in a 6% 
polyacrylamide gel and visualized by staining with ethidium bromide. Results of 2 independent experiments 
(Exp. #1 and Exp. #2) are shown. (I) DNA amounts of each sample were normalized by amplification of rRNA 
gene locus which is not influenced from restriction enzyme digestion and ligation. (B,D,F,H) Representation of 
the relative interaction frequency under the dCas9 and gRNA expression conditions. The band intensity of each 
3C-PCR product in 2 h post release samples represented in panel (A,C,E,G) was quantitatively measured with 
ImageJ and normalized using a standard curve derived from amplification of the standard template. Relative 
level of each 3 C interaction was graphed. Error bar represents standard deviation (n = 2). The interaction 
between upstream-downstream regions of Igf2 gene locus was used as a control which is not influenced by 
gRNA-dCas9 against the EGR1 gene locus. The original gel images are presented in Supplementary Fig. S11.
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and cloned into PGV-B (TOYOBO). The primers 5′-TCCTCCCCCGCACTCCCGGTTC-3′ and 5′-GGGAACACT 
GAGAAGCGTGC-3′ (EGR1+120 reverse primer) were used for amplification of the EGR1 promoter region har-
boring nucleotide positions from –720 to+120 relative to the TSS to make pEGR1 pro-720/+120 Luc. The primers 
5′-GCTCAGTTCGTGCTCACTGC-3′ and EGR1+120 reverse primer were used for amplification of the EGR1 
promoter region corresponding to nucleotide positions from –1358 to +120 to make pEGR1 pro-1358/+120 Luc. 
A CTCF binding site (CTCF BS) corresponding to nucleotide positions from –1227 to –1208 was changed from 
GGAACCTCCAGGGGGCAGCA to GGAAGTTATAAGCTTCAGCA to make pEGR1 pro-1358/+120ΔCTCF 
BS Luc. The sequencing information of nucleotide regions on pEGR1 pro-1358/+120ΔCTCF BS Luc correspond-
ing to the CTCF binding site are shown in Fig. S3A. To generate dCas9 cDNA, two amino acid point mutations 
were introduced into the Cas9 cDNA in pX330-U6-Chimeric_BB-CBh-hSpCas9 plasmid (a gift from Feng Zhang, 
Addgene plasmid #42230). Oligonucleotides containing a 20 nt guide sequence for the EGR1 upstream CTCF bind-
ing site (5′-CACCGAGGCAGCTGCGCCACCTAGT-3′ and 5′-AAACACTAGGTGGCGCAGCTGCCTC-3′) 
and downstream CTCF binding site (5′-CACCGTTGTGCTGGTGACCACAAGG-3′ and 5′-AAACCCTTGTGG 
TCACCAGCACAAC-3′), and promoter proximal CTCF binding site (5′-CACCGAGTGGAGAGGGAA 
CCTCCAG-3′ and 5′-AAACCTGGAGGTTCCCTCTCCACTC-3′) were phosphorylated, annealed, and ligated into 
Bbs I digested pX330-dCas9. To make a control template for 3 C assay, the DNA fragments correspond-
ing to the Igf2 gene locus were amplified by PCR and cloned into pBluescriptII SK + (pBS). The primers 
5′-GGAGCTCACTCTAGTCTCCAAGGCTATT-3′ and 5′-CTCACCTGTCTCCATAAAGCATGTGTCC-3′ 
were used for amplification of the Igf2 upstream region harboring nucleotide positions 11 kb upstream relative 
to the TSS to make pBS-Igf2-upstream. The primers 5′-CCTAGGATTGGAAGGACCCCATCATCTG-3′ and 
5′-CTGCAAGGTCAGGGGACATTGTTCAGGG-3′ were used for amplification of the Igf2 downstream region 
harboring nucleotide positions 102 kb downstream relative to the TSS to make pBS-Igf2-downstream. 5′-ends 
of PCR products were phosphorylated by T4 Polynucleotide Kinase and ligated into pBS digested with EcoR V.
Antibodies. Antibodies used in this study were anti-CTCF (rabbit polyclonal)33, anti-α-tublin (DM1-A, 
Sigma), anti-EGR1 (B-6, Santa Cruz), anti-FLAG (M2, Sigma) antibodies and rabbit normal IgG (Millipore).
Cellular extraction and western blot analysis. Toal cell lysats were prepared by lysing cells in sample 
loading buffer (62.5 mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 100 mM β-mercaptoetanol, 0.01% bromophenol 
blue). Proteins were separated by 7.5% SDS-PAGE and subjected to western blot analysis. The signal was detected 
by Chemi-Lumi One L (Nacalai) and ImageQuant LAS4000 (GE Healthcare Life Sciences).
Total RNA extraction and quantitative real-time PCR. Total RNA was prepared from cells using 
RNeasy mini kit (Qiagen) and RNase-free DNase I (Qiagen), and subjected to reverse transcription using 
ReverTra Ace reverse transcriptase (TOYOBO) with random 9 mer primers. Synthesized cDNA was used as tem-
plate for quantitative real-time PCR (qRT-PCR) using FastStart SYBR Green Master (Roche) with specific primer 
sets, 5′-CAGCCCTACGAGCACCTGAC-3′ and 5′-ACTCCTGCGGTGAAGGACAG-3′ for EGR1 pre-mRNA, 
5′-CTGTGCATCTACACCGACAACTC-3′ and 5′-CTCGGAGGAGCAGATATGTCAGA-3′ for CCND1 
pre-mRNA, 5′-GCAATGAAGGTGAAGGCCGGCG-3′ and 5′-TAACACGTGCGCTCGTGCTCCACCTC-3′ 
for 28 S rRNA.
ChIP assays. Cells were fixed by direct addition of formaldehyde to culture dishes at the final concentra-
tion of 0.5% and incubated at room temperature for 10 min. Cross-linking was terminated by the addition of 
glycine. Cells were washed with 125 mM glycine/PBS and collected by scraping. ChIP assays were carried out 
according to the protocol from Chromatin Immunoprecipitation Assay Kit (17–295; Millipore) with minor mod-
ifications. Elution buffer contains 1% SDS, 100 mM NaHCO3 and 10 mM DTT. The primers used here were as 
follows: 5′-AAACGGTGCCATATCCAGGCTG-3′ and 5′-TCCAGGGAGCGGAGGATGAG-3′ for EGR1 gene 
15 kb upstream region, 5′-GCTCAGTTCGTGCTCACTGC-3′ and 5′-GTTCCCTCTCCACTCCCAGC-3′ for 
EGR1 gene 1.2 kb upstream region, 5′-CAGGCACCTCTTAATGCTTGTC-3′ and 5′-GCCAGGGAAAGTT 
TGTGCTG-3′ for EGR1 gene 38 kb downstream region. To perform a specific PCR amplification from the pro-
moter proximal CTCF binding site corresponding to the transfected reporter plasmid, the primers used here 
were as follows: 5′-CCAAACTCATCAATGTATCTTATGG-3′ and 5′-GGCTTGGCGGCTCGGTGCTG-3′. The 
former primer corresponds to the unique region on the plasmid. The latter primer corresponds to the promoter 
proximal CTCF binding site in EGR1 gene. The quantitative PCR (qPCR) was performed using FastStart SYBR 
Green Master and Thermal Cycler Dice Real Time System (TaKaRa). The results were analyzed using Thermal 
Cycler Dice Real Time System Software Ver. 5.11. (TaKaRa).
3C assays. 3C assays were performed essentially as described previously34. Cells were fixed by direct addi-
tion of formaldehyde to culture dishes at the final concentration of 1% and incubated at room temperature for 
10 min. Cross-linking was terminated by the addition of glycine. Cells were washed with 125 mM glycine/PBS 
and collected by scraping. Cells were resuspended in Dpn II digestion buffer containing 0.3% SDS and incubated 
at 37 °C for 8 h. Triton X-100 was added at the concentration of 1.8%, and the samples were incubated at 37 °C 
for 1.5 h to sequester SDS. DNAs in samples were digested at 37 °C for 16 h with restriction enzyme Dpn II (New 
England Biolabs). The restriction enzyme was inactivated by the addition of SDS at the concentration of 1.6% and 
heating at 65 °C for 20 min. The samples were diluted by ligation buffer (66 mM Tris-HCl [pH 7.4], 5 mM MgCl2), 
to adjust concentration of DNA to 2.5 ng genomic DNA/μl each. Triton X-100 was added to 1% and incubated at 
37 °C for 1 h to sequester SDS. T4 DNA ligase (TOYOBO), DTT, and ATP were added and incubated at 16 °C for 
20 h followed by 30 min at room temperature. The samples were heated at 65 °C for 6 h to reverse cross-linking 
and incubated with Proteinase K (Nacalai) at 55 °C for 1 h. DNAs were purified from the samples by phenol/
chloroform/isoamyl alcohol extraction and ethanol precipitation. A typical size distribution of genome DNA 
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of uncut genome, Dpn II digested genome without ligation, and ligated genome DNA are shown in Fig. S5A. A 
control template for 3 C assay was prepared from the bacterial artificial chromosome (BAC) clone RP11–113M21 
containing EGR1 locus on human chromosome 5, pBS-Igf2-upstream, and pBS-Igf2-downstream. BAC DNA and 
plasmid DNA are mixed in equimolar amounts and digested with Dpn II. Digested DNA was randomly ligated 
by T4 DNA ligase. The random ligated DNA was purified and used as a standard template for semi-quantitative 
PCR. PCR was performed with primers shown in Table 1. Primer pairs for each PCR are shown in Table 2. The 
position of the restriction enzyme recognition site, CTCF motif, and position of primers in each of the nucleotide 
sequence is shown in Fig. S6. PCR products were separated in a 6% polyacrylamide gel and visualized by staining 
with ethidium bromide. Gel images were taken by Gel Documentation System (ATTO). Band intensities were 
measured by ImageJ35.
Luciferase assays. HeLa S3 cells were transfected with pEGR1 pro-720/+120 Luc, pEGR1 pro-1358/+120 
Luc, pEGR1 pro-1358/+120ΔCTCF BS Luc plasmids together with pRL-SV40 (Promega) plasmid. Renilla lucif-
erase expression plasmid pRL-SV40 was used as a normalizer. Transient transfection of plasmid DNA for reporter 
gene assay was performed using GeneJuice (Novagen). Cells were collected at 0, 1, 2, and 3 h post release from 
nocodazole treatment as described previously. The cells were lysed with lysis buffer (Renilla luciferase lysis buffer, 
Promega). The cell lysates were mixed with a firefly luciferase substrate (Promega) or rennilla luciferase substrate 
(Promega), and each luciferase activity was measured by Lumat LB9506 (BERTHOLD). Each value was normal-
ized by the renilla luciferase activity.
Time-lapse analysis. HeLa S3 cells were transfected with shEGFP or shCTCF#1 expression plasmid 
and cell cycle were synchronized as described above. Nocodazole arrested cells were collected and reattached 
to a poly-L-lysine coated 12-well plate. The plate was put in a chamber of ARRAYSCAN XTI (Thermo Fisher 
Scientific) and maintainted at 37 °C in 5% CO2. Then, cells were washed with PBS, and time-lapse images were 
collected by ARRAYSCAN XTI.
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